Chugai Slides After Ending Trials for Muscle Disorder Drug
Chugai Pharmaceutical Co. fell 7.3%, the largest intraday decline since August 2025, after the company said it had ended the development of an experimental drug for certain diseases that cause...
By Kanoko Matsuyama · Bloomberg
Chugai Pharmaceutical Co. fell 7.3%, the largest intraday decline since August 2025, after the company said it had ended the development of an experimental drug for certain diseases that cause muscle weakness.